"Navigating the Modern News Zoo so you don't have to."
Tuesday, October 14, 2025
Pulsed field ablation system shows promise for reducing ventricular tachycardia recurrence
Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation System for ventricular tachycardia (VT), have been published in Circulation. Results were also presented as a late-breaking trial at the 20th Annual International Symposium on Ventricular Arrhythmias (VT Symposium 2025), held in Philadelphia Oct. 10–11.
Dr Robert Lustig gets Fact-checked by MD PhD Doctor
- Brit Hume Predicts Renewed Saudi-Israeli Talks As Hamas Loses Grip On Region - Mariane Angela
- This Is the Best Week of the Year to Buy a House
- Elon Musk's Ambitious Plan: To Send One Million Humans to Mars within the Next Decade - Michael A. Medeiros
- Anti-vaccine groups melt down over RFK Jr. linking autism to Tylenol - Beth Mole
- The Evolution and Impact of Internet Jokes: A Closer Look at Prank.Chat - Bertha Stephens
- The Full Moons of 2024: A Comprehensive Guide to Their Names and Dates - Arya Chandran
Brandon Tatum Trying to Undermine Charlie Kirk’s Final Wishes for TPUSA
- To Bring Hostages Home, Israel Pays Very Steep Price - Steve Postal
- What to Make of the Trump DOJ’s Letitia James Indictment - Andrew C. McCarthy
- 5 Healthiest Pastas, Ranked by a Dietitian - Merve Ceylan
- The Lightbringer Acts Like a Petulant, Spoiled Child
- iOS 18 Elevates the iPhone with Unmatched Personalization and Intelligence - Michael A. Medeiros
- An Antidote To Peacemaker: The Perfect Comic Book Movie Is Now Streaming For Free - Chris Snellgrove
